Desensitization Strategies in Immunized Heart Transplant Recipients

Area of Science:

• Cardiology
• Immunology
• Transplantation Medicine

Background:

• Allosensitization (pre-transplant anti-HLA antibodies) increases wait times and mortality for heart transplant candidates.
• Desensitization protocols aim to reduce preformed donor-specific antibodies (pfDSAs) for safer transplantation.
• This review provides an overview of current desensitization strategies in heart transplantation.

Purpose of the Study:

• To review existing desensitization strategies for heart transplantation.
• To discuss the role of pfDSA reduction in overcoming the HLA antibody barrier.
• To highlight advancements in diagnostic precision for pfDSA characterization.

Main Methods:

• Review of current desensitization protocols and interventions.
• Analysis of diagnostic advancements in pfDSA detection (titer, complement-binding capacity).
• Evaluation of treatment strategies targeting antibody clearance, production, and graft damage.

Main Results:

• Desensitization can be performed pre- or peri-transplant.
• Protocols combining multiple drugs/interventions are effective.
• Improved immunoassays allow precise pfDSA characterization, potentially avoiding desensitization for acceptable antibodies.
• Successful protocols demonstrate optimal graft survival and freedom from rejection/vasculopathy.

Conclusions:

• Crossing the HLA barrier in heart transplantation is feasible and safe.
• Personalized therapy is crucial due to complex immune pathways.
• Comprehensive desensitization protocols are essential for managing pfDSAs.
• Advancements in diagnostics may refine the need for desensitization.